Furthermore, treatment with XGHP/aminophylline showed that PTGS2 expression significantly decreased in the COPD + XGHP group or COPD + Ami group compared with the COPD group (P < 0.05) (Figure 6). This evidence concerns the gene PTGS2 and chronic obstructive pulmonary disease.